| CTRI Number |
CTRI/2024/08/072582 [Registered on: 16/08/2024] Trial Registered Prospectively |
| Last Modified On: |
09/01/2026 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Ayurveda |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
Study to Test How Two Traditional Treatments Help Improve Uterine Health |
|
Scientific Title of Study
|
A single arm clinical study to evaluate the combined effect of Shatapushpa taila Nasya and Phala sarpi yoni pichu in improving the endometrial receptivity |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Prashant Zinjad |
| Designation |
PG Scholar |
| Affiliation |
Amrita School of Ayurveda |
| Address |
Department of Stree roga and Prasuti tantra,
Amrita School of Ayurveda
Amrita Vishwa Vidyapeetham,
Amritapuri, Clappana P.O.
Kerala, India
Kollam KERALA 690546 India |
| Phone |
7038477341 |
| Fax |
|
| Email |
prashantzinjad2@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Hemavathi S K |
| Designation |
HOD and Professor |
| Affiliation |
Amrita School of Ayurveda |
| Address |
Department of Stree roga and Prasuti tantra,
Amrita School of Ayurveda
Amrita Vishwa Vidyapeetham,
Amritapuri, Clappana P.O.
Kollam KERALA 690546 India |
| Phone |
9446962291 |
| Fax |
|
| Email |
hemavathi@ay.amrita.edu |
|
Details of Contact Person Public Query
|
| Name |
Dr Hemavathi S K |
| Designation |
HOD and Professor |
| Affiliation |
Amrita School of Ayurveda |
| Address |
Department of Stree roga and Prasuti tantra,
Amrita School of Ayurveda
Amrita Vishwa Vidyapeetham,
Amritapuri, Clappana P.O.
Kollam KERALA 690546 India |
| Phone |
9446962291 |
| Fax |
|
| Email |
hemavathi@ay.amrita.edu |
|
|
Source of Monetary or Material Support
|
| Sparsh Womens Hospital and IVF center |
|
|
Primary Sponsor
|
| Name |
Dr. Prashant Zinjad |
| Address |
Department of Stree roga and Prasuti tantra,
Amrita School of Ayurveda
Amrita Vishwa Vidyapeetham,
Amritapuri, Clappana P.O. |
| Type of Sponsor |
Other [self] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Prashant zinjad |
Sparsh Womens Hospital and IVF Center |
Plot no. ASG 44/45 sahyadri nagar, Ashwin Nagar, Nashik, Maharashtra 422010 Nashik MAHARASHTRA |
7038477341
prashantzinjad2@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 2 |
| Name of Committee |
Approval Status |
| SMBT ayurved ethics committee |
Approved |
| sparsh womens hospital and IVF center |
No Objection Certificate |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:N859||Noninflammatory disorder of uterus, unspecified. Ayurveda Condition: ARTAVAVAHA-SROTODUSHTIH, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | | 1 | Intervention Arm | Drug | Classical | | (1) Medicine Name: shatapushpa taila, Reference: kashyapa samhita, Shatapushpa-shatavari Adhyaya, Route: Nasal, Dosage Form: Taila, Dose: 1.5(ml), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: 0.75 ml in each nostril(2) Medicine Name: phala sarpi, Reference: Astanga hrudayam uttarstana 34 chapter 63 to 67 shloka, Route: Vaginal, Dosage Form: Ghrita, Dose: 5(ml), Frequency: od, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: sterile pichu will be dipped in phala sarpi and kept in vagina |
|
|
|
Inclusion Criteria
|
| Age From |
25.00 Year(s) |
| Age To |
35.00 Year(s) |
| Gender |
Female |
| Details |
Females in age group 20-35yrs, Having an endometrial thickness of less tha or equal to 7mm or having an Applebaum’s (USSR) Score less than 16 out of 20 in the Pre-test, With a Menstrual cycle between 24-38 days, Who are eligible for TVS scan.
|
|
| ExclusionCriteria |
| Details |
Subjects having compliance with the interventions Females who are already diagnosed with Carcinoma of the reproductive tract, Congenital anomalies of the reproductive tract, Active inflammatory disease, Sexually transmitted infections, and Uncontrolled systemic diseases such as diabetes and hypertension, Subjects who are on Oral-contraceptive from the last 3 menstrual cycles, Subjects unfit for nasya intervention.
|
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Change in Applebaums USSR score |
3 menstrual cycle of the patient |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Difference in menstrual cycle in terms of frequency, duration and flow volume |
3 menstrual cycle of the patient |
|
|
Target Sample Size
|
Total Sample Size="12" Sample Size from India="12"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 3 |
|
Date of First Enrollment (India)
|
30/08/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="3" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Closed to Recruitment of Participants |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
PROPOSED TITLE : “A SINGLE-ARM CLINICAL STUDY TO EVALUATE THE COMBINED EFFECT OF SHATAPUSHPA TAILA NASYA AND PHALA SARPI YONI PICHU IN IMPROVING ENDOMETRIAL RECEPTIVITY†INTRODUCTION : The ability of the endometrium to allow implantation is known as receptivity. Optimal receptivity is essential for a healthy pregnancy. Females who have poor endometrial quality may face various menstrual and infertility problems, often resulting from a thin endometrium. The endometrium undergoes changes during the menstrual cycle, and estrogen plays a critical role in the endometrial sensitivity to ovarian hormones. Any disturbance in estrogen levels can result in a thin endometrium. Treatment for a thin endometrium involves synthetic estrogen administration, which can cause severe side effects. Thus, alternative methods are required to regulate estrogen synthesis and improve endometrial quality. According to Sushruta Samhita, four crucial factors are required for conception in which “ Kshetra†is Garbhashaya, which can be correlated to endometrium. Acharya Sushruta has mentioned pre-conceptional care, whereas Dalhanacharya focuses on Garbhasthapana and Garbhastitikarana. Acharya Vishwamitra’s commentary on Sushruta Samhita mentions presence sukshma kesha pratikasha beeja raktavaha sira in garbhashaya which can be correlated in the context of garbhashya tarpana. Phalasarpi has Garbha sthapaka , Yoni doshahara, Putrapada, Pumsavana properties. In Kashyapa Samhita, Shatapushpa-Shatavari kapla adhyaya, Shatapushpa is mentioned as having properties of rutupravartani, yonivishodhana, putraprada and veeryakari. Shatapushpa also known as Anethum sowa Roxb contains phytoestrogens that exhibit properties similar to endogenous estrogen. Nasal administration allows for a quick local effect and has a direct effect on the hypothalamo-pituitary axis, which leads to ovarian stimulation and ultimately impacts the endometrium. Drug administration through the vaginal route is effective due to better drug bioavailability to the uterus, hence can be given to improve endometrium receptivity. METHODOLOGY : Minimum of 12 participants satisfying inclusion criteria will be selected from Sparsh women’s Hospital and IVF centre, after getting IEC clearance from SMBT Ayurveda College and CTRI registration.The baseline data will be assessed using Applebaum’s (USSR) score on the day of recruitment of the study, Day 15th of menstrual cycle (M1) after getting written informed consent. Treatment will be initiated with pratimarsha nasya using Shatapushpa taila from Day 6th – Day 13th of the immediate menstrual cycle (M2), Then from Day 15th-Day 21st of the same menstrual cycle (M2), yoni pichu with sterile Phalasarpi will be given. Post-assessment will be done on Day 15th of next menstrual cycle (M3) using Applebaum’s (USSR) score. This score will be compared with their initial score to determine the effectiveness of the treatment. DURATION OF THE STUDY – 18 MONTHS ESTIMATED COST – Approximately Rs. 67,000/- |